J&J Said to Face Demand to Raise Risperdal Settlement Offer

J&J Said to Face Demand to Raise Risperdal Settlement Offer

JB Reed/Bloomberg

The U.S. government has been investigating Risperdal sales practices since 2004, including allegations the company marketed the drug for unapproved uses, Johnson &Johnson has said in Securities and Exchange Commission filings. The company said it has been in negotiations with the U.S. to settle the investigation.